A detailed history of First Manhattan CO transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, First Manhattan CO holds 4,324 shares of LNTH stock, worth $396,943. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,324
Previous 4,324 -0.0%
Holding current value
$396,943
Previous $347,000 36.6%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$24.23 - $28.59 $29,657 - $34,994
1,224 Added 39.48%
4,324 $111,000
Q2 2021

Aug 16, 2021

BUY
$19.51 - $27.64 $60,481 - $85,684
3,100 New
3,100 $85,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.31B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.